Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
editorial
. 1997 Dec;61(6):1234–1238. doi: 10.1086/301659

PTEN: sometimes taking it off can be better than putting it on.

M P Myers, N K Tonks
PMCID: PMC1716096  PMID: 9399917

Full text

PDF
1234

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson K., Carballeira N., Magnusson K. E., Persson C., Stendahl O., Wolf-Watz H., Fällman M. YopH of Yersinia pseudotuberculosis interrupts early phosphotyrosine signalling associated with phagocytosis. Mol Microbiol. 1996 Jun;20(5):1057–1069. doi: 10.1111/j.1365-2958.1996.tb02546.x. [DOI] [PubMed] [Google Scholar]
  2. Barford D., Flint A. J., Tonks N. K. Crystal structure of human protein tyrosine phosphatase 1B. Science. 1994 Mar 11;263(5152):1397–1404. [PubMed] [Google Scholar]
  3. Barford D., Jia Z., Tonks N. K. Protein tyrosine phosphatases take off. Nat Struct Biol. 1995 Dec;2(12):1043–1053. doi: 10.1038/nsb1295-1043. [DOI] [PubMed] [Google Scholar]
  4. Barford D., Keller J. C., Flint A. J., Tonks N. K. Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. J Mol Biol. 1994 Jun 24;239(5):726–730. doi: 10.1006/jmbi.1994.1409. [DOI] [PubMed] [Google Scholar]
  5. Begum N., Sussman K. E., Draznin B. Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities. Diabetes. 1991 Dec;40(12):1620–1629. doi: 10.2337/diab.40.12.1620. [DOI] [PubMed] [Google Scholar]
  6. Chrzanowska-Wodnicka M., Burridge K. Tyrosine phosphorylation is involved in reorganization of the actin cytoskeleton in response to serum or LPA stimulation. J Cell Sci. 1994 Dec;107(Pt 12):3643–3654. doi: 10.1242/jcs.107.12.3643. [DOI] [PubMed] [Google Scholar]
  7. Cobb B. S., Parsons J. T. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527. Oncogene. 1993 Nov;8(11):2897–2903. [PubMed] [Google Scholar]
  8. Eng C., Murday V., Seal S., Mohammed S., Hodgson S. V., Chaudary M. A., Fentiman I. S., Ponder B. A., Eeles R. A. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet. 1994 Jun;31(6):458–461. doi: 10.1136/jmg.31.6.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Flint A. J., Tiganis T., Barford D., Tonks N. K. Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1680–1685. doi: 10.1073/pnas.94.5.1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gorlin R. J., Cohen M. M., Jr, Condon L. M., Burke B. A. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet. 1992 Oct 1;44(3):307–314. doi: 10.1002/ajmg.1320440309. [DOI] [PubMed] [Google Scholar]
  11. Howell L. D., Griffiths C., Slade L. W., Potts M., Kennelly P. J. Substrate specificity of IphP, a cyanobacterial dual-specificity protein phosphatase with MAP kinase phosphatase activity. Biochemistry. 1996 Jun 11;35(23):7566–7572. doi: 10.1021/bi9600409. [DOI] [PubMed] [Google Scholar]
  12. Klarlund J. K. Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteins. Cell. 1985 Jul;41(3):707–717. doi: 10.1016/s0092-8674(85)80051-9. [DOI] [PubMed] [Google Scholar]
  13. Laporte J., Hu L. J., Kretz C., Mandel J. L., Kioschis P., Coy J. F., Klauck S. M., Poustka A., Dahl N. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet. 1996 Jun;13(2):175–182. doi: 10.1038/ng0696-175. [DOI] [PubMed] [Google Scholar]
  14. Li D. M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 1997 Jun 1;57(11):2124–2129. [PubMed] [Google Scholar]
  15. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., McCombie R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997 Mar 28;275(5308):1943–1947. doi: 10.1126/science.275.5308.1943. [DOI] [PubMed] [Google Scholar]
  16. Liaw D., Marsh D. J., Li J., Dahia P. L., Wang S. I., Zheng Z., Bose S., Call K. M., Tsou H. C., Peacocke M. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet. 1997 May;16(1):64–67. doi: 10.1038/ng0597-64. [DOI] [PubMed] [Google Scholar]
  17. Marsh D. J., Dahia P. L., Zheng Z., Liaw D., Parsons R., Gorlin R. J., Eng C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet. 1997 Aug;16(4):333–334. doi: 10.1038/ng0897-333. [DOI] [PubMed] [Google Scholar]
  18. Myers M. P., Stolarov J. P., Eng C., Li J., Wang S. I., Wigler M. H., Parsons R., Tonks N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9052–9057. doi: 10.1073/pnas.94.17.9052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Neel B. G., Tonks N. K. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol. 1997 Apr;9(2):193–204. doi: 10.1016/s0955-0674(97)80063-4. [DOI] [PubMed] [Google Scholar]
  20. Nelen M. R., van Staveren W. C., Peeters E. A., Hassel M. B., Gorlin R. J., Hamm H., Lindboe C. F., Fryns J. P., Sijmons R. H., Woods D. G. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 1997 Aug;6(8):1383–1387. doi: 10.1093/hmg/6.8.1383. [DOI] [PubMed] [Google Scholar]
  21. Poon R. Y., Hunter T. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science. 1995 Oct 6;270(5233):90–93. doi: 10.1126/science.270.5233.90. [DOI] [PubMed] [Google Scholar]
  22. Rhei E., Kang L., Bogomolniy F., Federici M. G., Borgen P. I., Boyd J. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 1997 Sep 1;57(17):3657–3659. [PubMed] [Google Scholar]
  23. Steck P. A., Ligon A. H., Cheong P., Yung W. K., Pershouse M. A. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer. 1995 Apr;12(4):255–261. doi: 10.1002/gcc.2870120404. [DOI] [PubMed] [Google Scholar]
  24. Steck P. A., Pershouse M. A., Jasser S. A., Yung W. K., Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997 Apr;15(4):356–362. doi: 10.1038/ng0497-356. [DOI] [PubMed] [Google Scholar]
  25. Takagi T., Moore C. R., Diehn F., Buratowski S. An RNA 5'-triphosphatase related to the protein tyrosine phosphatases. Cell. 1997 Jun 13;89(6):867–873. doi: 10.1016/s0092-8674(00)80272-x. [DOI] [PubMed] [Google Scholar]
  26. Tashiro H., Blazes M. S., Wu R., Cho K. R., Bose S., Wang S. I., Li J., Parsons R., Ellenson L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 1997 Sep 15;57(18):3935–3940. [PubMed] [Google Scholar]
  27. Yuvaniyama J., Denu J. M., Dixon J. E., Saper M. A. Crystal structure of the dual specificity protein phosphatase VHR. Science. 1996 May 31;272(5266):1328–1331. doi: 10.1126/science.272.5266.1328. [DOI] [PubMed] [Google Scholar]
  28. Zhang S. H., Eckberg W. R., Yang Q., Samatar A. A., Tonks N. K. Biochemical characterization of a human band 4.1-related protein-tyrosine phosphatase, PTPH1. J Biol Chem. 1995 Aug 25;270(34):20067–20072. doi: 10.1074/jbc.270.34.20067. [DOI] [PubMed] [Google Scholar]
  29. van Heyningen V. Genetics. One gene--four syndromes. Nature. 1994 Jan 27;367(6461):319–320. doi: 10.1038/367319a0. [DOI] [PubMed] [Google Scholar]
  30. von Deimling A., Louis D. N., von Ammon K., Petersen I., Hoell T., Chung R. Y., Martuza R. L., Schoenfeld D. A., Yaşargil M. G., Wiestler O. D. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg. 1992 Aug;77(2):295–301. doi: 10.3171/jns.1992.77.2.0295. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES